ZOFENOPRIL

DRUG3 trials

Sponsors

Novartis Pharma AG, Medical University Of Vienna, Menarini International Operations Luxembourg SA

Conditions

Diabetes mellitus Type 2Heart FailureHypertension

Phase 2

A multi-center, randomized, placebo- and active-controlled, parallel-group, 24-week proof of concept and dose-finding study to evaluate efficacy, safety, and tolerability of XXB750 in patients with heart failure

CompletedCTIS2023-504678-39-00

Novartis Pharma AGHeart Failure

Start: 2024-03-13End: 2024-11-08Target: 424Updated: 2024-11-08

Phase 4

Effectiveness and Safety of Combination of Amlodipine and Zofenopril in Hypertensive Patients Versus Each Monotherapy

CompletedNCT05279807

Menarini International Operations Luxembourg SAHypertension

Start: 2021-10-15End: 2022-04-28Updated: 2024-10-21

NT-proBNP Selected PreventiOn of cardiac eveNts in a populaTion of dIabetic patients without A history of Cardiac disease; a prospective randomized trial

Not yet recruitingCTIS2024-519051-28-01

Medical University Of ViennaDiabetes mellitus Type 2

Target: 448Updated: 2025-02-17